3h
INQUIRER.net USA on MSNLeen Kawas on AI and drug discovery: The ethical challenges that will define the next decadeLooking ahead, Leen Kawas believes that the successful integration of AI into drug discovery will require thoughtful ...
Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...
Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...
Q4 2024 Earnings Call Transcript March 24, 2025 Operator: Hello, and welcome to the Moleculin Biotech Fourth Quarter and Full ...
The new framework aims to shorten the time on register new medications in Israel, making drugs more readily available to the ...
Enzymes, the core catalysts in life, drive critical biological processes ranging from metabolic regulation to energy ...
Transparent, well-designed clinical trials are a must. FastWave Medical's Scott Nelson has advice on how to get there.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results